During the past decade, St. Lawrence Health System conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Lawrence Health System" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "ConforMIS, Inc." with 1 trials sponsored, "Daniel Benjamin" with 1 trials sponsored, "Eyal Kedar" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Lawrence Health System" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Lawrence Health System" are "Systemic Lupus Erythematosus" (4 trials), "Ankylosing Spondylitis" (1 trials), "Axial Spondyloarthritis" (1 trials), "Covid19" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "St. Lawrence Health System" in a lesser frequency.

Most popular intervention types in "St. Lawrence Health System" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (3 trials), "Abatacept" (1 trials), "ConforMIS Total Knee Replacement System" (1 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Lawrence Health System" are 8 trials for "All" genders.

Currently, there are NaN active trials in "St. Lawrence Health System". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Lawrence Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Lawrence Health System, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".